Clinical outcomes of premature infants with and without chronic neonatal lung disease

Clinical outcomes of premature infants with and without chronic neonatal lung disease - PRIORITY

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00038197

Enrollment

Registered

2025-10-20

Start date

2021-09-29

Completion date

Unknown

Last updated

2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

P27.1

Interventions

Group 1: The study comprises a retrospective evaluation of lung function tests.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Premature infants < 32 weeks gestational age

Exclusion criteria

Exclusion criteria: Severe congenital malformations (e.g., hypoplastic left heart syndrome, severe pulmonary hypoplasia, or congenital diaphragmatic hernia), chromosomal abnormalities (e.g., trisomy 13 or 18), congenital metabolic disorders, and the decision to pursue palliative care immediately after birth.

Design outcomes

Primary

Measure	Time frame
Primary target parameters are respiratory rate, tidal volume, tPTEF% (ratio of time to peak expiratory flow to total expiratory time), static compliance, resistance, time constant, and functional residual capacity (FRCp).	—

Secondary

Measure	Time frame
The secondray endpoint is the diagnosis of bronchopulmonary dysplasia (neonatal chronic lung disease of the newborn; nCLD).	—

Countries

Germany

Contacts

Public ContactKai Martin Förster

Klinikum der LMU

kai.foerster@med.uni-muenchen.de+4989440056800

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026